Benzimidazole compounds and use thereof for treating Alzheimer's Disease or Huntington's Disease
US10584120B1 · kind B1 · utility
0Cited by
2References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 27, 2019 |
| Grant date | Mar 10, 2020 |
| Priority date | — |
| Expiry date | Aug 27, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Benzimidazole compounds of formula (I), shown below, are disclosed. The compounds are potent human glutaminyl cyclase inhibitors. Also disclosed is a pharmaceutical composition containing one of these compounds and a pharmaceutical acceptable carrier, as well as a method of treating Alzheimer's disease or Huntington's disease by administering to a subject in need thereof an effective amount of such a compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.